Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVO) EBT: 2009-2025

Historic EBT for Evotec SE (EVO) over the last 5 years, with Sep 2025 value amounting to -$50,223.

  • Evotec SE's EBT rose 2.44% to -$50,223 in Q3 2025 from the same period last year, while for Sep 2025 it was -$293.8 million, marking a year-over-year decrease of 239.01%. This contributed to the annual value of -$207.3 million for FY2024, which is 139.04% down from last year.
  • Latest data reveals that Evotec SE reported EBT of -$50,223 as of Q3 2025, which was up 99.98% from -$207.1 million recorded in Q4 2024.
  • Over the past 5 years, Evotec SE's EBT peaked at $38.9 million during Q4 2021, and registered a low of -$207.1 million during Q4 2024.
  • In the last 3 years, Evotec SE's EBT had a median value of -$50,850 in 2025 and averaged -$49.0 million.
  • Examining YoY changes over the last 5 years, Evotec SE's EBT showed a top increase of 125.56% in 2022 and a maximum decrease of 504.29% in 2022.
  • Over the past 5 years, Evotec SE's EBT (Quarterly) stood at $38.9 million in 2021, then plummeted by 504.29% to -$157.2 million in 2022, then spiked by 44.88% to -$86.7 million in 2023, then plummeted by 138.99% to -$207.1 million in 2024, then increased by 2.44% to -$50,223 in 2025.
  • Its last three reported values are -$50,223 in Q3 2025, -$207.1 million for Q4 2024, and -$51,478 during Q3 2024.